Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

HISTORICAL FACTS: Andrew left - Caught on Camera

Short seller convicted of fraud after boasting ‘it’s like taking candy from a baby’

The investor took to social media after the verdict, writing, ‘This is not over’

The Independent UK

Short seller Andrew Left convicted of securities fraud

A federal grand jury in California has convicted short seller Andrew Left of securities fraud

AAP

Who Is Andrew Left? Wall Street's Prominent Short Seller Found Guilty Of Fraud, May Face Jail Time

Andrew Left, founder of Citron Research, was found guilty of securities fraud, accused of manipulating stocks and defrauding investors, potentially facing 45 years in prison.

International Business Times UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Long Bitcoin, Short MicroStrategy: Citron Research 'Proud Of The Timing' One Year Later

Short seller Citron Research, led by Andrew Left, made a prediction one year ago. The firm bet on Bitcoin (CRYPTO: BTC), but against the Bitcoin treasury company Strategy Inc (NASDAQ:MSTR). Here are the results of the trade.

Benzinga

This Little-Known Nuclear Energy Stock Is ‘the Most Important Company in America’

Amentum Holdings has quickly become a key nuclear and defense contractor with a discounted valuation, record backlog, and growing analyst attention, making it a quietly strategic play on U.S. energy security and military modernization.

Barchart

Nvidia Hits $5 Trillion: Is This The Next Dot-Com Bubble Or AI Gold Rush? The 56x Return Investor Speaks

As chipmaker NVIDIA Corp. (NASDAQ:NVDA) surges past $5 trillion in market capitalization, several prominent analysts have reacted to the stock’s unrelenting rally, amid growing concerns regarding its sustainability and speculations of an AI bubble.

Benzinga

Short Seller Andrew Left Recalls Bet On Nebius As It Soars Over 130% In 2025: 'Just A Pat On The Back' From When NBIS Was At $20 Per Share

Famed short-seller Andrew Left of Citron Research is taking a victory lap on a bullish call, celebrating his firm’s early bet on AI infrastructure company Nebius Group NV (NASDAQ:NBIS).

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Opendoor Attacked By Short Seller—Stock Pops Anyway

Citron Research, led by famed short-seller Andrew Left, targeted Opendoor Technologies, Inc. (NASDAQ:OPEN) in a social media post on Friday. Opendoor investors shrugged off the attack, and the stock climbed.

Benzinga

Jim Cramer Sees Palantir Riding MongoDB's Momentum: Sets Bold 24% Upside Target — Says 'Bears Didn't See Mongo Coming!'

Television host Jim Cramer is once again reiterating his bullish stance on Palantir Technologies Inc. (NASDAQ:PLTR), tying the stock’s potential and his latest price target to the recent surge in MongoDB Inc. (NASDAQ:MDB).

Benzinga

Palantir New All-Time Highs In 2025? Less Than 50% Say Yes In New Poll

Palantir Technologies (NASDAQ:PLTR) stock has gained more than 100% year-to-date, hitting new all-time highs in August before a recent pullback.

Benzinga

Palantir's AI Edge: PEG Ratio Outshines Salesforce—'Sleeper Valuation' Defying P/E Skeptics?

In a landscape where high Price-to-Earnings (P/E) ratios often scare investors, a different metric defies skeptics that AI powerhouse, Palantir Technologies Inc. (NASDAQ:PLTR), which was battered last week for its high valuations following a Citron Research report, is not quite overpriced.

Benzinga

How AI darling Palantir became the S&P 500’s best and worst stock of 2025, climbing 144% before shedding value in 6 straight sessions

Over $73 billion has been wiped off high-flying Palantir’s market cap in recent days.

Fortune

PLTR Stock Has Declined Over 15% In Past 5 Sessions, But This Tech Bull Says Palantir Remains 'Favorite'

Despite a sharp sell-off that has seen Palantir Technologies Inc. (NYSE:PLTR) shares plummet nearly 15% in the last five sessions, Wedbush Securities analyst Dan Ives is urging investors to see the dip as a buying opportunity.

Benzinga

Palantir Short Seller Andrew Left's Citron Now Compares It To Databricks: 'PLTR Is A $40 Stock, And Every Real AI Leader Keeps Reminding Us'

Short-seller Andrew Left‘s Citron Research intensified its campaign against Palantir Technologies Inc. (NYSE:PLTR) on Wednesday, posting a direct comparison to private competitor Databricks that highlights Palantir’s slower growth on several key metrics.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Short Seller Andrew Left Says 'OpenAI At $500 Billion Puts Palantir At $40' — And That's Generous

Renowned short-seller Andrew Left's Citron Research has issued a bearish report on Palantir Technologies Inc. (NASDAQ:PLTR), arguing the stock is significantly overvalued and its price is "detached from fundamentals and analysis".

Benzinga

Marjorie Taylor Greene Keeps Buying UnitedHealth Stock Along With Fellow Investors Buffett And Burry

Shares of UnitedHealth Group (NYSE:UNH) soared on Friday with news that several prominent investors had purchased shares of the health insurance company.

Benzinga

GameStop Short Seller Bets Against Palantir — Goes Long UnitedHealth Alongside Buffett, Burry

UnitedHealth Group (NYSE:UNH) stock is soaring Friday morning with a handful of large investors revealing long positions in the health insurance company via quarterly 13F filings.

Benzinga

Short Seller Slams Jim Cramer Over Palantir, Accuses Him Of Hyping 'High-Multiple, Hype-Driven Narrative' After $200 Price Target Call

Famed short-seller Andrew Left's Citron Research publicly challenged CNBC's Jim Cramer over his bullish stance on Palantir Technologies Inc. (NASDAQ:PLTR).

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

GameStop Short Seller Andrew Left Is Taking On Retail Investors Again, Now Says Palantir Stock Is 'Beyond Overvalued'

Citron Research founder and famed short seller Andrew Left announced a new short pick on Wednesday during an appearance on Fox Business.

Benzinga

Andrew Left Doubles Down On Rocket Companies: 'This Isn't A Meme,' It's A 'Housing Juggernaut' In The Making (CORRECTED)

Editor's Note: This article has been updated to correct the individual’s name in the headline.

Evening Standard

Prince Andrew 'unsurprised' by accuser Virginia Giuffre's car crash claims, friends of Duke say

The campaigner, who accused the Duke of York of sexually abusing her when she was 17, revealed she had ‘days to live’ following the collision with a school bus in Australia

Evening Standard

What happened to Virginia Giuffre? Everything we know as Epstein accuser 'fights for life' after car crash

The sex trafficking survivor shocked fans on Monday after revealing she was hit by a bus and has ‘days to live’

Barchart

Citron Research Just Identified This 1 Stock to Buy as a ‘Hidden’ AI Winner

Former short seller Citron Research is growing bullish on Teladoc's growth potential.

Fortune

Are famous short-sellers going extinct? The exit of Hindenburg Research and Andrew Left shows the risky trade is shrinking

Indicted short-seller Andrew Left tells Fortune a chilling effect is making “everyone think twice.”

Benzinga

Andrew Left's Citron Research Says Nvidia-Backed Nebius Is The Next 'AI Wall Street Darling' — Stock Moves Up 14%

Shares of Nebius Group NV (NASDAQ:NBIS) jumped 13.90% on Tuesday after Citron Research highlighted the company’s potential to become the next artificial intelligence sensation on Wall Street, citing its deep ties with NVIDIA Corp. (NASDAQ:

1 2

People

Marjorie Taylor Greene

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations